Clinical trial
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
NCT00166244 · Erasmus Medical Center, Other · Completed
Key facts
| NCT number | NCT00166244 |
|---|---|
| Title | Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation |
| Official title | An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation |
| Lead sponsor | Erasmus Medical Center, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | De Novo Renal Transplant Recipient. |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil |
| Enrollment | 901 |
| Start date | May 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Feb 12, 2009 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Estonia, France, Germany, Lithuania, Netherlands and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: